Gamaleya Research Institute of Epidemiology and Microbiology; Institute of Rheumatology, Moscow, Russia
Testing of immunocompromised patients for markers of β-herpesviruses — human herpesvirus type 6 (HHV-6) and cytomegalovirus (CMV), as well as γ-herpesvirus — Epstein-Barr virus (EBV), revealed that all mentioned infections are frequently detected, mainly as mixed infections. Chronic HHV-6 infection was diagnosed in more than half of the patients, whereas markers of acute phase of CMV and EBV infections were detected in 25% and 15% of patients respectively.
Zh. Mikrobiol. (Moscow), 2009, No. 1, P. 79—80